Vischer with co-lead and new investors in Aktiia’s funding round
Vischer advised the co-lead and other new investors in Aktiia’s oversubscribed USD 42m Series-B funding-round. Pursuant to the transaction, the blood pressure intelligence platform reached a total funding of USD 100m to date.
The participants
Earlybird Health and Wellington Partners co-led the funding round in question, with new investors Kfund and naturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures.
The Vischer team
The Vischer team working on the matter featured partner Matthias Staehelin (corporate/M&A, pictured), managing associate Vincent S. Reardon (corporate/M&A), senior associate Timothy Woodtli (corporate/M&A), associate Lucas Sturzenegger (corporate/M&A), associate Rahel Widmer (corporate/M&A), junior associate Stefanie Havalda, junior associate Celine Kappler, as well as partner Nadia Tarolli (tax), managing associate Nora Heuberger (tax) and associate Diego Anzante (tax).
